Gestational diabetes & diabetes in pregnancy

A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes

DiabetologiaPublished Observational study

Authors' conclusion

Precision categorisation of GDM using HOMA2-S and HOMA2-B does not provide useful diagnostic or prognostic information, but did distinguish a novel subgroup of patients with GDM, characterised by an isolated postprandial defect in insulin sensitivity.

Study context

Population
Pregnant women with ≥1 risk factor for gestational diabetes mellitus (GDM) undergoing 75 g OGTT at nine hospital sites; GDM diagnosis per NICE guidance
Participants
1,308 women
Exposure
Pathophysiological GDM subtypes vs NGT
  • NGTn = 1,027reference
  • Insulin-resistant GDMn = 135
  • Insulin-insufficient GDMn = 73
  • Bothn = 2
  • GDM-neithern = 71
Outcome
Classification by enhanced specimen handling
Methodological detailsmulticentre, nine hospital sites
  • Multicentre
  • Nine hospital sites

Main finding

As reported in the abstract

Classified as GDM
281/1308 (21.5%)

Observational data: associations, not effects.

Further findings

GDM-neither phenotype

Relatively insulin-sensitive fasting but marked post-load hyperglycaemia and hyperinsulinaemia, suggesting isolated postprandial defect in insulin sensitivity

Pregnancy outcomes

Most GDM subgroups had pregnancy outcomes comparable to normoglycaemic women; HOMA2-B and HOMA2-S were weak predictors
Maternal BMI predicted a similar number of outcomes to HOMA2-S; no additional predictive value of HOMA2-S
Similar findings with different indices and standard specimen handling

Original publication

A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes. Diabetologia. Published 2 December 2024. doi:10.1007/s00125-024-06334-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.